Physician profile
Mackenzie Hamilton
NPI 1477118057
$10,915.83
in general payments reported to CMS, 2019-2025
25 companies · $2,331 in 2025
The $2,331 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11.70 · 2023: $2,611 · 2024: $5,962 · 2025: $2,331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,305 · Travel and Lodging: $3,263 · Education: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,305.41 |
| Travel and Lodging | $3,263.21 |
| Education | $335.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $3,212.10 | 2023-2025 | Glidesheath Slender, Angio-Seal, R2p Misago |
| Boston Scientific Corporation | $874.74 | 2023-2025 | General - Vascular Access, Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $854.28 | 2023-2025 | Wainua, Farxiga, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $831.08 | 2023-2025 | Lifevest |
| Medtronic, INC. | $785.91 | 2023-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Abiomed | $513.67 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $465.64 | 2023-2025 | |
| Heartflow, INC. | $461.46 | 2024-2025 | |
| Abbott Laboratories | $455.74 | 2024-2025 | Cardiomems |
| Shockwave Medical, INC | $391.83 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.92 | 2023-2025 | Jardiance |
| Penumbra, INC. | $279.28 | 2024-2025 | Indigo System, Penumbra System |
| Zoll Circulation INC | $263.25 | 2023-2024 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Cvrx, INC. | $252.31 | 2023-2025 | Barostim Neo System |
| Stryker Corporation | $231.26 | 2025 | Flowtriever |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $124.97 | 2023 | |
| Kestra Medical Technology Services, INC. | $101.12 | 2024-2025 | Assure Wcd |
| Idorsia Pharmaceuticals US INC | $89.72 | 2024 | Tryvio |
| Irhythm Technologies, INC. | $89.58 | 2024 | Zio Monitor, Zio Xt Patch |
| Philips North America LLC | $75.82 | 2025 | Igt Devices Undivided |
| Chiesi USA, INC. | $64.88 | 2024-2025 | Kengreal |
| Amgen INC. | $61.70 | 2022-2024 | Repatha |
| Cook Medical LLC | $57.69 | 2024 | Advance |
| Inari Medical, INC. | $55.83 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $16.05 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.